All stocks Β· FABINO
FE

FABINO ENTERPRISES LIMITED

FABINO BSE Drug Manufacturers - Specialty & Generic Healthcare

Fabino Enterprises Limited manufactures, markets, trades, and packages pharmaceutical and other wellness focused consumer products in India. It offers tablets, ointments syrups, etc. for various medical treatments in al…

ISIN INE0DRT01018
Listed β€”
Quarters tracked β€”
Filings 9 docs

About

Fabino Enterprises Limited manufactures, markets, trades, and packages pharmaceutical and other wellness focused consumer products in India. It offers tablets, ointments syrups, etc. for various medical treatments in allopathic and certain herbal categories as well as food and wellness products under the Fabino and Keepshine brand names. The company also exports wellness and FMCG products, such as coffee, malt powder, protein powder, and hair shampoo. It markets its products through its own distribution network and sales force. The company was formerly known as Fabino Life Sciences Limited and changed its name to Fabino Enterprises Limited in June 2024. Fabino Enterprises Limited was incorporated in 2011 and is based in Sonipat, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in β€” check back soon.

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales 11.4318.006.013.364.193.067.522.76
Expenses 12.9717.835.903.334.092.997.202.44
Operating Profit -1.540.170.110.030.100.070.320.32
OPM % -13.470.941.830.892.392.294.2611.59
Other Income 1.300.290.000.020.010.000.000.00
Interest 0.130.130.020.010.010.010.200.29
Depreciation 0.100.070.030.030.030.020.020.03
Profit before tax -0.470.260.060.010.070.040.100.00
Tax % -25.5350.0016.670.0028.5725.0030.00β€”
Net Profit -0.360.130.050.010.050.030.070.00
EPS in Rs -1.710.620.240.050.240.254.670.00
Dividend Payout % 0.000.000.000.000.000.000.00β€”

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital 2.102.102.102.102.101.200.150.15
Reserves 1.832.192.062.012.000.100.520.45
Borrowings 1.111.610.840.410.050.311.082.52
Other Liabilities 12.287.114.500.500.480.651.835.43
Total Liabilities 17.3213.019.505.024.632.263.588.55
Fixed Assets 0.370.460.240.150.170.160.080.10
CWIP 0.000.000.000.000.000.000.000.00
Investments 0.050.050.050.000.000.000.000.00
Other Assets 16.9012.509.214.874.462.103.508.45
Total Assets 17.3213.019.505.024.632.263.588.55

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Cash from Operating Activity 0.59-0.12-2.99-0.68-1.90-0.452.440.18
Cash from Investing Activity -0.012.11-0.18-0.01-0.05-0.100.00-0.01
Cash from Financing Activity -0.630.730.430.342.470.45-2.37-0.18
Net Cash Flow -0.052.72-2.75-0.350.52-0.100.070.00
Free Cash Flow 0.58-0.41-3.11-0.69-1.95-0.542.440.17
CFO/OP % -38.006.00-2,700.00-2,233.00-1,900.00-600.00772.0056.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debtor Days 404.92177.43377.75274.84125.44158.64113.09338.55
Inventory Days 28.6926.5688.59147.24174.8362.6115.36988.71
Days Payable 374.56152.06294.4045.7834.7663.9477.341,024.81
Cash Conversion Cycle 59.0551.93171.94376.29265.51157.3151.11302.45
Working Capital Days 136.99103.21282.40444.30292.70165.8051.9319.84
ROCE % -6.227.161.680.462.782.9812.32β€”

Shareholding Pattern

% holding β€” latest first
Holder Mar 2026 Sep 2025 Mar 2025 Sep 2024 Mar 2024 Sep 2023 Mar 2023 Sep 2022 Mar 2022
Promoters 56.82 56.82 56.82 56.82 56.82 56.82 56.82 56.82 56.82
Public 43.18 43.18 43.18 43.18 43.18 43.18 43.18 43.19 43.18
No. of Shareholders 141 129 137 138 138 151 160 168 195